FindTrial
Sign In

"A clinical trial to study the effects of two drugs, propofol and etomidate on blood pressure, seizure duration, and recovery profile during electro - convulsive therapy."

â??A comparative study on the effects of propofol and etomidate on haemodynamic stability, seizure duration and recovery profileduring ECT.â??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018031
Enrollment
40
Registered
2019-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G978- Other intraoperative and postprocedural complications and disorders of nervous system

Interventions

Intervention1: Propofol: Electro convulsive therapy using propofol Control Intervention1: Etomidate: Electro convulsive therapy using Etomidate

Sponsors

SVIMS University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status I,â?¡ psychiatric patients who will undergo consecutive electroconvulsive therapies between age 18- 60 years

Exclusion criteria

Exclusion criteria: H/O recent myocardial infarction, recent cerebrovascular accident Angina Pectoris Congestive Heart Failure Major Bone Fractures Pregnancy and lactation Aneurysms of major vessels Porphyria Patients with shock and hypovolemia

Design outcomes

Primary

MeasureTime frame
To analyse the blood presuure, heart rateTimepoint: 2 months—

Secondary

MeasureTime frame
To study seizure duration and recovery profile in patients undergoing ECTTimepoint: 6 months—

Countries

India

Contacts

Public ContactDr Andal Venkataraman

SVIMS University

drandalvenkat@gmail.com9493547656

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026